METHOD FOR PREDICTING EFFICIENCY OF NEOADJUVANT CHEMIO-RADIATION THERAPY IN PATIENTS WITH RECTAL CANCER DURING PRIMARY MRI STUDIES Russian patent published in 2021 - IPC A61B6/00 G06T7/10 A61N5/00 

Abstract RU 2754495 C2

FIELD: medicine.

SUBSTANCE: invention relates to medicine, namely to oncology, and can be used to predict the effectiveness of neoadjuvant chemoradiation therapy (NDCT) in patients with rectal cancer during primary MRI examination. Texture analysis of the MRI image of the primary tumor in T2-WI mode is performed. For analysis, MRI images obtained in the axial plane at the level of the center of the tumor using an FSE pulse sequence with high spatial resolution are used: TR (sequence repetition period) - 4020 ms, TE (echo appearance time) - 97 ms, slice thickness/step - 3.0/0.3 mm, FoV (field of view size) - 250 mm, MTX (matrix size/pixels) - 286×512. Next, the selected images are loaded into the Mazda ver.4.6 program and the image segmentation is carried out. The texture parameters are determined by the GLCM gray level co-occurrence matrix method at a distance of 2 pixels and in four different directions - 0°, 45°, 90°, 135°. The obtained values are averaged and, using a computer program, the parameters of texture analysis are automatically calculated, which are used to predict the effectiveness of NHLT based on the scoring system. AngScMom - if it is greater than or equal to 0.0016, then 1 point is assigned, if less than 0.0016 - 0 points. SumofSqs - if less than or equal to 101.88, then 1 point is assigned, if more than 101.88 - 0 points. SumVarnc - if less than or equal to 277.51, then 1 point is assigned, if more than 277.51 - 0 points. SumEntrp - if less than or equal to 1.81, then 1 point is assigned, if more than 1.81 - 0 points. Entropy - if less than or equal to 2.88, then 1 point is assigned, if more than 2.88 - 0 points. If the sum of the received points is greater than or equal to 3, then a good response to NDCT is predicted. If the sum of the received points is less than 3, then no response to NDCT is predicted.

EFFECT: invention provides prediction of the effectiveness of NDCT due to quantitative data of 5 parameters of texture analysis (AngScMom, SumVarnc, SumofSqs, Entropy, SumEntrp) T2-WI magnetic resonance imaging of the tumor during the primary MRI study.

1 cl, 11 dwg, 4 tbl, 4 ex

Similar patents RU2754495C2

Title Year Author Number
METHOD FOR ASSESSING THE EFFECTIVENESS OF THE NEOADJUVANT CHEMORADIOTHERAPY IN PATIENTS SUFFERING RECTAL CANCER 2019
  • Dajneko Yana Aleksandrovna
  • Berezovskaya Tatyana Pavlovna
  • Nevolskikh Aleksej Alekseevich
  • Mozerov Sergej Alekseevich
  • Ivanov Aleksandr Aleksandrovich
  • Kaprin Andrej Dmitrievich
RU2705257C2
METHOD OF TREATING PATIENTS WITH METASTASES IN LYMPH NODES AND OLIGOMETASTATIC DISEASE IN BONES OF SKELETON IN PROSTATE CANCER 2018
  • Ustinova Tatyana Vasilevna
  • Bolotina Larisa Vladimirovna
  • Nyushko Kirill Mikhajlovich
  • Pajchadze Anna Aleksandrovna
  • Krasheninnikov Aleksej Arturovich
  • Khmelevskij Evgenij Vitalevich
  • Kaprin Andrej Dmitrievich
  • Alekseev Boris Yakovlevich
RU2695348C2
METHOD FOR COMBINED TREATMENT OF PATIENTS WITH LOCALLY ADVANCED RECTAL CANCER USING NEOADJUVANT RADIATION THERAPY AND CONSOLIDATING CHEMOTHERAPY 2021
  • Kaprin Andrei Dmitrievich
  • Ivanov Sergei Anatolevich
  • Petrov Leonid Olegovich
  • Erygin Dmitrii Valerevich
  • Orekhov Ivan Anatolevich
  • Gulidov Igor Aleksandrovich
  • Titova Liudmila Nikolaevna
  • Karpov Aleksandr Anatolevich
RU2770989C2
METHOD FOR PREDICTION OF PROBABILITY OF DEGREE OF MALIGNANCY OF ACINAR PROSTATE ADENOCARCINOMA IN MALES BY GLEASON SCALE 7=3+4 AND 7=4+3 ON BASIS OF BPMRT-RADIOMICS 2023
  • Kryuchkova Oksana Valentinovna
  • Shchepkina Elena Viktorovna
  • Kuznetsov Anton Igorevich
RU2825524C1
METHOD OF COMBINED TREATMENT OF MUSCULO-INVASIVE BLADDER CANCER T3-T4 N0-+M0 2019
  • Rerberg Andrej Georgievich
  • Vorobev Nikolaj Vladimirovich
  • Bolotina Larisa Vladimirovna
  • Kornietskaya Anna Leonidovna
  • Bolotova Rimma Sangaevna
RU2713443C2
METHOD FOR PREOPERATIVE DETERMINATION OF MORPHOLOGICAL RISK FACTORS FOR PROGRESSION IN PATIENTS WITH PROSTATE CANCER 2021
  • Kneev Aleksei Iurevich
  • Shkolnik Mikhail Iosifovich
  • Bogomolov Oleg Alekseevich
  • Zharinov Gennadii Mikhailovich
RU2770983C1
METHOD OF TREATMENT OF LOCALLY ADVANCED SQUAMOUS CELL CANCER OF ANAL CANAL 2023
  • Nevolskikh Aleksei Alekseevich
  • Mikhaleva Iuliia Iurevna
  • Titova Liudmila Nikolaevna
  • Gulidov Igor Aleksandrovich
  • Petrov Leonid Olegovich
  • Berezovskaia Tatiana Pavlovna
  • Avdeenko Violetta Andreevna
  • Ivanov Sergei Anatolevich
  • Kaprin Andrei Dmitrievich
RU2809447C2
PROGNOSIS METHOD FOR DISEASE PROGRESSION IN PATIENTS WITH GASTROINTESTINAL CANCER AFTER TREATMENT 2021
  • Mikhailova Galina Fedorovna
  • Tsepenko Viktoriia Viktorovna
  • Shkavrova Tatiana Gennadevna
  • Cherkesov Vladimir Nikolaevich
  • Shegai Petr Viktorovich
  • Ivanov Sergei Anatolevich
  • Kaprin Andrei Dmitrievich
RU2758079C2
METHOD OF NEOADJUVANT THERMOCHEMORADIATION TREATMENT OF RECTAL CANCER 2018
  • Kaprin Andrej Dmitrievich
  • Ivanov Sergej Anatolevich
  • Petrov Leonid Olegovich
  • Gulidov Igor Aleksandrovich
  • Erygin Dmitrij Valerevich
  • Karpov Aleksandr Anatolevich
  • Titova Lyudmila Nikolaevna
  • Kobets Aleksandr Ivanovich
RU2704205C2
METHOD FOR ULTRASONIC EXAMINATION OF PATIENTS DIAGNOSED WITH ENDOMETRIAL CANCER 2020
  • Vostrov Aleksandr Nikolaevich
  • Mitina Larisa Anatolevna
  • Zuzieva Kheda Badrudinovna
  • Stepanov Stanislav Olegovich
  • Mukhtarulina Svetlana Valerevna
  • Novikova Elena Grigorevna
  • Anpilogov Sergei Vladimirovich
RU2739108C2

RU 2 754 495 C2

Authors

Berezovskaia Tatiana Pavlovna

Daineko Iana Aleksandrovna

Nevolskikh Aleksei Alekseevich

Ivanov Sergei Anatolevich

Kaprin Andrei Dmitrievich

Dates

2021-09-02Published

2021-03-17Filed